$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B
In its results release of 3 Nov 2026 (Q3 FY2026), Amgen gave 6 forecasts in figures, among them revenue of $38.90B to $39.70B for FY2026. Over the last two years, results landed above the company's own last range 2 of 8 times, within it 2 and below it 4.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 3 Nov 2026
| Measure | Period | Guidance | As stated |
|---|
| Revenue | FY2026 | $38.90B to $39.70B | Total revenues in the range of $38.9 billion to $39.7 billion. |
|---|
| EPS · GAAP | FY2026 | $18.34 to $19.28 | On a GAAP basis, EPS in the range of $18.34 to $19.28, and a tax rate in the range of 14.5% to 16.0%. |
|---|
| EPS · Adjusted | FY2026 | $22.90 to $23.70 | On a non-GAAP basis, EPS in the range of $22.90 to $23.70, and a tax rate in the range of 15.0% to 16.5%. |
|---|
| Capital expenditures | FY2026 | About $2.60B | Capital expenditures to be approximately $2.6 billion. |
|---|
| Tax rate · GAAP | FY2026 | 14.5% to 16% | GAAP tax rate guidance 14.5% - 16.0% |
|---|
| Tax rate · Adjusted | FY2026 | 15% to 16.5% | Non-GAAP tax rate guidance 15.0% - 16.5% |
|---|
Source: the company's earnings release.
Guidance against results above 2 · within 2 · below 4
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| Revenue | FY2026 | $38.90B to $39.70B | Raised twice | — | To come |
|---|
| EPS · GAAP | FY2026 | $18.34 to $19.28 | Raised twice | — | To come |
|---|
| EPS · Adjusted | FY2026 | $22.90 to $23.70 | Raised twice | — | To come |
|---|
| Capital expenditures | FY2026 | About $2.60B | Unchanged | — | To come |
|---|
| Tax rate · GAAP | FY2026 | 14.5% to 16% | Unchanged | — | To come |
|---|
| Tax rate · Adjusted | FY2026 | 15% to 16.5% | Unchanged | — | To come |
|---|
| Revenue | FY2025 | $35.80B to $36.60B | Raised twice | $36.75B | Above the range |
|---|
| EPS · GAAP | FY2025 | $13.76 to $14.60 | Raised once, lowered once | $14.23 | Within the range |
|---|
| Capital expenditures | FY2025 | $2.20B to $2.30B | Lowered once | $1.86B | Below the range |
|---|
| Tax rate · GAAP | FY2025 | 14.5% to 16% | Raised once | 14.09% | Below the range |
|---|
| Revenue | FY2024 | $33.00B to $33.80B | Given once | $33.42B | Within the range |
|---|
| EPS · GAAP | FY2024 | $8.71 to $9.56 | Given once | $7.56 | Below the range |
|---|
| Capital expenditures | FY2024 | About $1.30B | Given once | $1.10B | Below the range |
|---|
| Tax rate · GAAP | FY2024 | 9% to 10.5% | Given once | 11.26% | Above the range |
|---|
AMGN in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.